LPCN Lipocine Inc

P/E --
Forward P/E 5.64
Price/Sales 8.4
Beta 0.402
Div Yield --
Market Cap --

Company Analysis

Latest News

Lipocine Revenue Plummets as Postpartum Drug Fails, FDA Meeting Looms

Lipocine Revenue Plummets as Postpartum Drug Fails, FDA Meeting Looms

Lipocine reported second-quarter 2026 revenue of $190,099. This represents a sharp decline from $622,849 in the prior-year period. The drop resulted from the...